$TNON: Record Q2 revenue ($1.3M) + FDA clearance — history shows a median 11.0% next-day move
How TNON has reacted before
| Report | Next-day move |
|---|---|
| May 2026 | -11.5% |
| Mar 2026 | -3.9% |
| Aug 2025 | -16.2% |
| May 2025 | -10.5% |
Median absolute move 11% · higher 0 of 4 · n=4
Tenon Medical, Inc. Common Stock reported record Q2 revenue of $1.3 million, driven by strategic initiatives and FDA clearance for the Catamaran SI Joint Fusion System.
How $TNON has reacted to earnings
| Report | Next-day |
|---|---|
| May 2026 | -11.5% |
| Mar 2026 | -3.9% |
| Aug 2025 | -16.2% |
| May 2025 | -10.5% |
Base rate (n=4):
- Median absolute next-day move: 11.0%
- Higher next day: 0 of 4
- Biggest up: -3.9%
- Biggest down: -16.2%